-+ 0.00%
-+ 0.00%
-+ 0.00%

NEKTAR THERAPEUTICS : UBS INITIATES COVERAGE WITH NEUTRAL RATING AND TARGET PRICE $53

路透·10/12/2026 13:40:09

請登錄查看新聞詳情